Advantages and Disadvantages of Using St. John's Wort as a Treatment for Depression.
Level 5 - mechanism / opinion, no new human data
Narrative review without formal systematic review methodology or meta-analysis
PubMed 36299970 · doi:10.7759/cureus.29468
What was done
The authors searched PubMed, JAMA network, Springer Link, Elsevier, Google Scholar, and Scientific Progress for literature published between 2011 and August 2021 on St. John's wort (Hypericum perforatum) for depression and antidepressant interactions. After removing irrelevant and non-English articles, 27 papers were included in a qualitative narrative review.
What was found
The abstract reports no numerical data, effect sizes, or confidence intervals. St. John's wort was described as superior to placebo in mild and moderate depression, comparable in efficacy to tricyclic antidepressants, and comparable to or more effective than SSRIs such as fluoxetine. It was also reported to reduce postmenopausal depression. While better tolerated with fewer adverse effects than standard antidepressants, it carries risks of CYP450-mediated drug interactions and potentially fatal serotonin syndrome when combined with other serotonergic medications.
Why it matters
This review highlights that while St. John's wort has clinical efficacy comparable to standard antidepressants for mild-to-moderate depression, its severe pharmacokinetic interactions require careful clinical oversight.
Limits
The abstract provides no quantitative effect estimates, confidence intervals, or total participant sample size. It omits formal risk-of-bias evaluation, details on extract standardization or dosing, and excluded non-English studies.
Cited by
- supports Combining St. John's wort with an SSRI medication can adversely interfere with serotonin levels.